Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Despite increasing size of unrelated donor (URD) registries and the global CB inventory racial disparities in access to URD and CB grafts persist: A prospective 10 year analysis of 1,112 patients
    Meeting Abstract

    Boughan, K. M.; Dahi, P.; Devlin, S. M.; Byam, C.; Yoo, Y.; Mazis, C.; Davis, E.; Nhaissi, M.; Paulson, J.; Wells, D. S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival with organ toxicity predicting for overall survival (OS) and non-relapse mortality (NRM) in older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation (Allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Adrianzen Herrera, D. A.; Cho, C.; Maloy, M.; Nieves, J.; Devlin, S. M.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A phase 1/2 trial of carfilzomib + high dose melphalan conditioning for auto-HCT followed by carfilzomib maintenance for patients with relapsed multiple myeloma
    Meeting Abstract

    Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Innis-Shelton, R.; Saad, A.; Salzman, D.; Hamadani, M.; Tamari, R.; Williams, L.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Combining the disease risk index (DRI) and hematopoietic cell transplantation comorbidity index (HCT-CI) provides a comprehensive prognostic model for CD34-selected allogeneic HCT
    Meeting Abstract

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Maloy, M.; Meagher, R.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Using HapLogic™ & recipient ancestry: The likelihood of identifying an 8/8 HLA-matched unrelated donor can be accurately predicted at the time of the preliminary search markedly improving search efficiency & speed to allograft: An 830 patient analysis
    Meeting Abstract

    Davis, E.; Devlin, S. M.; Cooper, C.; Nhaissi, M.; Paulson, J.; Wells, D. S.; Scaradavou, A.; Giralt, S. A.; Papadopoulos, E. B.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Application of the CIBMTR Survival Outcomes Calculator to CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Devlin, S. M.; Maloy, M.; Horowitz, M. M.; Rizzo, J. D.; Giralt, S. A.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Timing of initiation of defibrotide (DF) post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol
    Meeting Abstract

    Grupp, S. A.; Richardson, P. G.; Smith, A. R.; Triplett, B.; Kernan, N. A.; Antin, J. H.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • PHF6 mutations defines a subgroup of mixed phenotype of acute leukemia with aberrant T-cell differentiation
    Meeting Abstract

    Xiao, W.; Pastore, F.; Getta, B.; Hultquist, A.; Shaffer, B. C.; Giralt, S. A.; Rampal, R. K.; Arcila, M. E.; Levine, R. L.; Roshal, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save